We therefore performed immunofluorescent double labeling of ZEB1 and IDH1 R132H in four IDH-mutant GBM cases (Fig 3A, S2 Fig) and quantified colocalization after blinded manual scoring of individual nuclei from at least three fields of views per tumor (S1 File). This evidence concerns the gene ZEB1 and neoplasm.